Search

This article discusses the perspectives and experiences of primary care providers (PCPs) in managing hidradenitis suppurativa (HS), a chronic inflammatory skin condition. The study surveyed 93 PCPs in the United States and found that many lacked confidence in diagnosing and managing HS, particularly in terms of comorbidities and surgical discussions. The majority of PCPs referred HS patients to dermatology and prescribed topical and oral antibiotics. The study highlights the need for education and collaboration between PCPs and dermatologists to improve HS management and early diagnosis. However, the study's limitations include a small sample size and unclear response rate. [Extracted from the article]

Hidradenitis suppurativa (HS) is a chronic inflammatory dermatosis that is often recalcitrant to multiple medical treatments. Respondents learned about HS surgery from an HS support group (45.4%), their healthcare provider (HCP) (44.4%), or an online resource (26.0%). Acknowledgments An anonymous survey was distributed with permission through online social media HS support groups (HS Connect, Hope for HS, and HS Warriors) with permission between October 2021 and January 2022. [Extracted from the article]

Dear Editor, Hidradenitis suppurativa (HS) is an inflammatory dermatosis characterized by recurrent abscesses, draining sinus tracts, and scars affecting intertriginous areas. Although pain is most commonly reported, itch is another prevalent but under-studied symptom.1 We aim to characterize the prevalence of pain and itch by anatomic location and lesion type, and identify activities affected by these symptoms in HS patients. This figure shows the frequency of pain and itch in various lesion morphologies gl To our knowledge, this is the largest HS survey study on pain and itch (856 participants), and the first to characterize symptoms by lesion type.1-3 Our study demonstrates that the majority of HS patients experience both pain and itch. [Extracted from the article]

Dear Editor, Hidradenitis suppurativa (HS) is a chronic inflammatory disorder. From December 2017 to September 2019, an anonymous online survey asking about demographics and HS disease characteristics was distributed at HS specialty clinics and Facebook HS support groups. HS progression accelerates as more anatomic regions become involved, consistent with a previous report.3 While the groin may be the most commonly affected area overall followed by the axilla,1,3 we found that HS lesions are most likely to first appear in the axilla. [Extracted from the article]

Dear Editor, Rosacea is a common, chronic inflammatory dermatosis affecting approximately 5.5% of adults globally.1 Low health literacy is a known barrier to patient education and improved disease outcomes. We investigated the readability and quality of content provided by top websites for rosacea-related patient information. As a marker for timeliness of the websites' content, we analyzed whether treatment option with oxymetazoline hydrochloride cream, which was FDA approved for treatment of rosacea in 2017, was mentioned. [Extracted from the article]

Dear Editor, Hidradenitis suppurativa (HS) is an oftentimes debilitating skin condition characterized by recurring abscesses and sinus tracts, typically in intertriginous regions.[1] HS patients have an increased utilization of high-cost settings (emergency department, inpatient hospitalization).[[2]] Historically HS has been treated by many different specialties but owned by none.[4] In this study, we sought to analyze the breakdown of specialties that diagnose and manage HS patients at an academic medical center and examine utilization of the HS specialty clinic. Among the 1023 patients, initial HS diagnosis was made by primary care providers (PCPs) for 339 (33%) patients and by dermatologists for 274 (27%) patients (Fig.). Sixty-seven (7%) patients went to the emergency department, 52 (5%) patients to urgent care, and 32 (3%) patients were hospitalized at least once for HS. [Extracted from the article]